These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24555822)

  • 41. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
    Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein.
    Ye L; Wang T; Tang L; Liu W; Yang Z; Zhou J; Zheng Z; Cai Z; Hu M; Liu Z
    J Pharm Sci; 2011 Nov; 100(11):5007-17. PubMed ID: 21721007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorption Properties of Luteolin and Apigenin in Genkwa Flos Using In Situ Single-Pass Intestinal Perfusion System in the Rat.
    He X; Song ZJ; Jiang CP; Zhang CF
    Am J Chin Med; 2017; 45(8):1745-1759. PubMed ID: 29121796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing regional differences in intestinal absorption of UK-343,664 in rat: possible role in dose-dependent pharmacokinetics.
    Kaddoumi A; Fleisher D; Heimbach T; Li LY; Cole S
    J Pharm Sci; 2006 Feb; 95(2):435-45. PubMed ID: 16381015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-glycoprotein increases portal bioavailability of loperamide in mouse by reducing first-pass intestinal metabolism.
    Dufek MB; Knight BM; Bridges AS; Thakker DR
    Drug Metab Dispos; 2013 Mar; 41(3):642-50. PubMed ID: 23288866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Absorption kinetics of atractylenolide I in intestines of rats].
    Wang C; Duan H; He L
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1430-4. PubMed ID: 19771879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marked impact of P-glycoprotein on the absorption of TAK-427 in rats.
    Takeuchi T; Nonaka M; Yoshitomi S; Higuchi T; Ebihara T; Maeshiba Y; Kawase M; Asahi S
    Biopharm Drug Dispos; 2008 Sep; 29(6):311-23. PubMed ID: 18651556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines.
    Chinn DC; Holland WS; Yoon JM; Zwerdling T; Mack PC
    Pediatr Blood Cancer; 2012 Jun; 58(6):885-90. PubMed ID: 21796766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect.
    Zhang X; Zhang T; Ye Y; Chen H; Sun H; Zhou X; Ma Z; Wu B
    Eur J Pharm Biopharm; 2015 Aug; 94():30-41. PubMed ID: 25936860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS).
    Liu W; Liu H; Sun H; Dong D; Ma Z; Wang Y; Wu B
    Xenobiotica; 2014 May; 44(5):455-64. PubMed ID: 24191862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
    Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
    Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disposition of orally administered a promising chemotherapeutic agent flavopiridol in the intestine.
    Xia B; Liu X; Zhou Q; Feng Q; Li Y; Liu W; Liu Z
    Drug Dev Ind Pharm; 2013 Jun; 39(6):845-53. PubMed ID: 22563974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on absorption sites of quinidine and methotrexate in rat intestine.
    Murakami T; Yokooji T; Mori N
    Pharmazie; 2010 Jun; 65(6):440-7. PubMed ID: 20614693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P-glycoprotein limits the absorption of the anti-HIV drug zidovudine through rat intestinal segments.
    Quevedo MA; Nieto LE; Briñón MC
    Eur J Pharm Sci; 2011 Jun; 43(3):151-9. PubMed ID: 21540109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis.
    Rice JW; Veal JM; Fadden RP; Barabasz AF; Partridge JM; Barta TE; Dubois LG; Huang KH; Mabbett SR; Silinski MA; Steed PM; Hall SE
    Arthritis Rheum; 2008 Dec; 58(12):3765-75. PubMed ID: 19035474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.